Annual CAPEX
$4.32 M
-$3.54 M-45.09%
December 31, 2023
Summary
- As of February 7, 2025, STRO annual capital expenditures is $4.32 million, with the most recent change of -$3.54 million (-45.09%) on December 31, 2023.
- During the last 3 years, STRO annual CAPEX has fallen by -$2.81 million (-39.47%).
- STRO annual CAPEX is now -71.84% below its all-time high of $15.32 million, reached on December 31, 2021.
Performance
STRO CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$828.00 K
+$72.00 K+9.52%
September 30, 2024
Summary
- As of February 7, 2025, STRO quarterly capital expenditures is $828.00 thousand, with the most recent change of +$72.00 thousand (+9.52%) on September 30, 2024.
- Over the past year, STRO quarterly CAPEX has dropped by -$613.00 thousand (-42.54%).
- STRO quarterly CAPEX is now -84.70% below its all-time high of $5.41 million, reached on June 30, 2021.
Performance
STRO Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$3.47 M
+$500.00 K+16.83%
September 30, 2024
Summary
- As of February 7, 2025, STRO TTM capital expenditures is $3.47 million, with the most recent change of +$500.00 thousand (+16.83%) on September 30, 2024.
- Over the past year, STRO TTM CAPEX has dropped by -$844.00 thousand (-19.56%).
- STRO TTM CAPEX is now -77.35% below its all-time high of $15.32 million, reached on December 31, 2021.
Performance
STRO TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
STRO CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -45.1% | -42.5% | -19.6% |
| 3 y3 years | -39.5% | -42.5% | -19.6% |
| 5 y5 years | +177.1% | -42.5% | -19.6% |
STRO CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -71.8% | at low | -75.4% | +152.4% | -77.3% | +16.8% |
| 5 y | 5-year | -71.8% | +24.0% | -84.7% | +152.4% | -77.3% | +16.8% |
| alltime | all time | -71.8% | +177.1% | -84.7% | +2200.0% | -77.3% | +853.6% |
Sutro Biopharma CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $828.00 K(+9.5%) | $3.47 M(+16.8%) |
| Jun 2024 | - | $756.00 K(+69.5%) | $2.97 M(-22.2%) |
| Mar 2024 | - | $446.00 K(-69.0%) | $3.82 M(-11.5%) |
| Dec 2023 | $4.32 M(-45.1%) | $1.44 M(+339.3%) | $4.32 M(-30.9%) |
| Sep 2023 | - | $328.00 K(-79.6%) | $6.24 M(-6.2%) |
| Jun 2023 | - | $1.60 M(+70.3%) | $6.65 M(-8.2%) |
| Mar 2023 | - | $942.00 K(-72.0%) | $7.25 M(-7.8%) |
| Dec 2022 | $7.86 M(-48.7%) | $3.37 M(+356.2%) | $7.86 M(+11.8%) |
| Sep 2022 | - | $738.00 K(-66.5%) | $7.03 M(-37.7%) |
| Jun 2022 | - | $2.20 M(+41.7%) | $11.29 M(-22.2%) |
| Mar 2022 | - | $1.55 M(-38.8%) | $14.50 M(-5.4%) |
| Dec 2021 | $15.32 M | $2.54 M(-49.2%) | $15.32 M(+6.3%) |
| Sep 2021 | - | $5.00 M(-7.7%) | $14.41 M(+16.3%) |
| Jun 2021 | - | $5.41 M(+127.8%) | $12.39 M(+41.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $2.38 M(+46.2%) | $8.74 M(+22.6%) |
| Dec 2020 | $7.13 M(+104.8%) | $1.63 M(-45.4%) | $7.13 M(-5.6%) |
| Sep 2020 | - | $2.98 M(+68.5%) | $7.55 M(+44.0%) |
| Jun 2020 | - | $1.77 M(+131.5%) | $5.25 M(+32.2%) |
| Mar 2020 | - | $763.00 K(-62.8%) | $3.97 M(+14.0%) |
| Dec 2019 | $3.48 M(+123.6%) | $2.05 M(+207.2%) | $3.48 M(+56.1%) |
| Sep 2019 | - | $667.00 K(+36.4%) | $2.23 M(+16.0%) |
| Jun 2019 | - | $489.00 K(+77.2%) | $1.92 M(+30.8%) |
| Mar 2019 | - | $276.00 K(-65.4%) | $1.47 M(-5.7%) |
| Dec 2018 | $1.56 M(-53.0%) | $798.00 K(+122.3%) | $1.56 M(+105.1%) |
| Sep 2018 | - | $359.00 K(+897.2%) | $759.00 K(+89.8%) |
| Jun 2018 | - | $36.00 K(-90.1%) | $400.00 K(+9.9%) |
| Mar 2018 | - | $364.00 K | $364.00 K |
| Dec 2017 | $3.32 M(-24.5%) | - | - |
| Dec 2016 | $4.39 M | - | - |
FAQ
- What is Sutro Biopharma annual capital expenditures?
- What is the all time high annual CAPEX for Sutro Biopharma?
- What is Sutro Biopharma annual CAPEX year-on-year change?
- What is Sutro Biopharma quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Sutro Biopharma?
- What is Sutro Biopharma quarterly CAPEX year-on-year change?
- What is Sutro Biopharma TTM capital expenditures?
- What is the all time high TTM CAPEX for Sutro Biopharma?
- What is Sutro Biopharma TTM CAPEX year-on-year change?
What is Sutro Biopharma annual capital expenditures?
The current annual CAPEX of STRO is $4.32 M
What is the all time high annual CAPEX for Sutro Biopharma?
Sutro Biopharma all-time high annual capital expenditures is $15.32 M
What is Sutro Biopharma annual CAPEX year-on-year change?
Over the past year, STRO annual capital expenditures has changed by -$3.54 M (-45.09%)
What is Sutro Biopharma quarterly capital expenditures?
The current quarterly CAPEX of STRO is $828.00 K
What is the all time high quarterly CAPEX for Sutro Biopharma?
Sutro Biopharma all-time high quarterly capital expenditures is $5.41 M
What is Sutro Biopharma quarterly CAPEX year-on-year change?
Over the past year, STRO quarterly capital expenditures has changed by -$613.00 K (-42.54%)
What is Sutro Biopharma TTM capital expenditures?
The current TTM CAPEX of STRO is $3.47 M
What is the all time high TTM CAPEX for Sutro Biopharma?
Sutro Biopharma all-time high TTM capital expenditures is $15.32 M
What is Sutro Biopharma TTM CAPEX year-on-year change?
Over the past year, STRO TTM capital expenditures has changed by -$844.00 K (-19.56%)